Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Novo Nordisk A/S - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 April 2018

Novo Nordisk A/S
Posted on: 30 Apr 18

Bagsværd, Denmark, 30 April 2018 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred.

Referring to Company Announcement no 34/2018 dated 24 April 2018, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 30 April 2018.

Further information

Anne Margrethe Hauge+45 4442 3450
Ken Inchausti (US)+1 609 786 8316
Investors :    
Peter Hugreffe Ankersen+45 3075 9085
Anders Mikkelsen+45 3079 4461
Christina Kjær+45 3079 3009

 Company Announcement no. 35 / 2018

CA20180430 - Novo Nordisk CA Voting rights_UK

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via GlobeNewswire

Last updated on: 01/05/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.